Clinical and preclinical studies have shown that extra virgin olive oil (EVOO), a major component of the Mediterranean diet, has beneficial effects on brain aging and cognition. Individuals with Down syndrome develop age-dependent cognitive decline and synaptic dysfunction. However, whether EVOO intake is beneficial in Down syndrome is not known.
Objective:
In this study, by implementing a mouse model of Down syndrome, we aimed to investigate the effect that chronic administration of EVOO has on memory, synaptic function, and neuroinflammation.
Methods:
Starting at 4 months of age Ts65dn mice were randomized to receive EVOO for 5 months in their diet, after which they were tested for learning and memory impairment. After euthanasia, synaptic function was measured in freshly obtained hippocampal slices, whereas brain tissues were assessed for inflammatory biomarkers.
Results:
Compared with controls, mice receiving EVOO had a significant improvement in learning and spatial memory. Additionally, field potential recordings showed that treated mice had an improvement in synaptic function. Finally, array analysis showed that EVOO modulated the expression levels of several inflammatory biomarkers.
Conclusions:
Chronic administration of EVOO to a mouse model of Down syndrome has beneficial effects on memory impairments, synaptic function deficits and neuroinflammation. Our findings provide additional support for the potential therapeutic effects of EVOO also in individuals with Down syndrome.
BullMJ. Down syndrome. N Engl J Med2020; 382: 2344–2352.
2.
McCarronMMcCallionPReillyE, et al.A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome. J Intell Disabil Res2017; 61: 843–852.
3.
WisemanFKAl-JanabiTHardyJ, et al.A genetic cause of Alzheimer’s disease: mechanistic insights from Down syndrome. Nat Rev Neurosci2015; 16: 564–574.
4.
HithersayRStartinCMHamburgS, et al.Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol2019; 76: 152–160.
5.
GardenerSLRainey-SmithSR. The role of nutrition in cognitive function and brain ageing in the elderly. Curr Nutr Rep2018; 7: 139–149.
6.
AnastasiouCAYannakouliaMKontogianniMD, et al.Mediterranean lifestyle in relation to cognitive health: results from the HELIAD study. Nutrients2018; 10: 1557.
7.
GuYNievesJWSternY, et al.Food combination and Alzheimer’s disease risk: a protective diet. Arch Neurol2010; 67: 699–706.
8.
BertiVWaltersMSterlingJ, et al.Mediterranean Diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. Neurology2018; 90: e1789–e1798.
9.
Guasch-FerreMLiYWilletWC, et al.Consumption of olive oil and risk of total and cause-specific mortality among U.S. adults. J Am Coll Cardiol2022; 79: 101–112.
10.
KaddumiADenneyTSDeshpandeG, et al.Extra virgin olive oil enhances blood brain barrier function in mild cognitive impairment: a randomized controlled trial. Nutrients2022; 14: 5102.
11.
LaurettiENenovMDincerO, et al.Extra virgin olive oil improves synaptic activity, short-term plasticity, memory, and neuropathology in a tauopathy model. Aging Cell2020; 19: e13076.
12.
Al RihaniSBDarakjianLLKaddoumiA. Oleocanthal-rich extra virgin olive oil restores the blood-brain-barrier function through NLRP3 inflammasome inhibition simultaneously with autophagy induction in TgSwDI mice. ACS Chem Neurosci2019; 10: 3543–3554.
13.
BatarsehYSKaddoumiA. Oleocanthal-rich extra virgin olive oil enhances donezepil effect reducing amyloid-beta load and related toxicity in a mouse model of Alzheimer’s disease. J Nutr Biochem2018; 55: 113–123.
14.
RuedaNFlórezJMartínez-CuéC. Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. Neural Plast2012; 2012: 584071.
15.
UcedaMFriasL.Harvest dates: evolution of the fruit oil content, oil composition and oil quality. In: Proceedings of the 2nd Seminario Oleicola Internacional. International Olive Oil Council, Cordoba, 1975. p.125–130.
16.
OJEC. Official Journal of the European Community COMMISSION DELEGATED REGULATION (EU) 2015/1830 of 8 July 2015 amending Regulation (EEC) No 2568/ 91 on the characteristics of olive oil and olive-residue oil and on the relevant methods of analysis. Commission Delegated Regulation (EU) 2022/2104 of 29 July 2022 Supplementing Regulation (EU) No. 1308/2013 of the European Parliament and of the Council as Regards the Marketing Standards for Olive Oil and Which Repeals Regulation (EEC) No. 2568/91 of the Commission and the Implementing Regulation (EU) n. 29/2012 of the Commission; Official Journal of the European Union: Brussels, Belgium, 2022. 2015.
17.
TaticchiASonia EspostoS, et al.High vacuum-assisted extraction affects virgin olive oil quality: impact on phenolic and volatile compounds. Food Chem2021; 342: 128369.
18.
LiJGBlassBPraticὸD. Beneficial effect of a small pharmacologic chaperone on the established Alzheimer’s disease phenotype. J Alzheimers Dis2023; 91: 463–469.
19.
VagnozziANGiannopouosPFPraticòD. Brain 5-lipoxygenase overexpression worsens memory, synaptic integrity and tau pathology in the P301S mice. Aging Cell2018; 17: e12695.
20.
CurtisMESmithTNenovM, et al.Retomer stabilization improves cognitive function and synaptic plasticity in a mouse model of Down syndrome. J Alzheimers Dis2023; 94: 513–518.
21.
TsolakiMLazarouEKozoriM, et al.Randomized clinical trial of Greek high phenolic early harvest extra virgin olive oil in mild cognitive impair. The MICOIL pilot study. J Alzheimers Dis2020; 78: 801–817.
22.
Valls-PedretCSala-VilaASerra-MirM, et al.Mediterranean Diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med2015; 175: 1094–1103.
23.
TzekakiEETsolakiMGeromichalosGD, et al.Extra virgin olive oil consumption from mild cognitive impairment patients attenuates oxidative stress and nitrative stress reflecting on the reduction of the PARP levels and DNA damage. Exp Gerontol2021; 156: 111621.
24.
TripoliEGiammancoMTabacchiG, et al.The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health. Nutr Res Rev2005; 18: 98–112.
25.
QosaHMohamedLABatarsehYS, et al.Extra virgin olive oil attenuates amyloid-B and tau pathologies in the brain of TgSwDi mice. J Nutr Biochem2015; 26: 1479–1490.
26.
TajmimACuevas-OcampoAKSiddiqueAB, et al.(-)-Oleocanthal nutraceuticals for Alzheimer's disease amyloid pathology: novel oral formulations, therapeutic, and molecular insights in 5xFAD transgenic mice model. Nutrients2021; 13: 1702.
27.
LaurettiEIulianoLPraticoD. Extra-virgin olive oil ameliorates cognition and neuropathology of the 3xtg mice: role of autophagy. Ann Clin Transl Neurol2017; 4: 564–574.
28.
HeraultYDelabarJMFisherEMC, et al.Rodent models in Down syndrome research: impact and future opportunities. Dis Model Mech2017; 10: 1165–1186.
29.
PuFYinSChenH, et al.Oleuropein improves long term potentiation at perforant path-dentate gyrus synapses in vivo. Chinese Herbal Med2015; 7: 255–260.
30.
LuccariniIGrossiCRigacciS, et al.Oleuropein aglycone protects against pyroglutamylated-3 amyloid b toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging2015; 36: 684–663.
31.
LengFEdisonP. Neuroinflammation and microglial activation in Alzheimer’s disease: where do we go from here?Nat Rev Neurol2012; 17: 157–172.
32.
SiZZZouCJMeiX, et al.Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications. Neural Regen Res2023; 18: 708–715.
33.
LaporteVAit-GhezalaGVolmarCH, et al.CD40 Deficiency mitigates Alzheimer's disease pathology in transgenic mouse models. J Neuroinflammation2006; 3: 3.
34.
BecherBBlainMAntelJP. CD40 Engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol2000; 102: 44–50.
35.
CisternasPGherardelliCGutierrezJ, et al.Adiponectin and resistin modulate the progression of Alzheimeŕs disease in a metabolic syndrome model. Front Endocrinol2023; 14: 1237796.
36.
WilcockDN. Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer's disease. Curr Gerontol Geriatr Res2012; 170276: 1–10.
37.
AhmedMJohnsonNRBoydTD, et al.Innate immune system activation and neuroinflammation in Down syndrome and neurodegeneration: therapeutic targets or partners?Front Aging Neurosci2012; 13: 718426.
38.
RoufosseF. Targeting the interleukin-5 pathway for treatment of eosinophilic conditions other than asthma. Front Med (Lausanne)2018; 5: 49.
39.
ZhouYLiCLiD, et al.IL-5 blocks apoptosis and tau hyperphosphorylation induced by Aβ25-35 peptide in PC12 cells. J Physiol Biochem2017; 73: 259–266.
40.
ArendWPMalyakMGuthridgeCJ, et al.Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol1998; 16: 27–55.
41.
KitazawaMChengDTsukamotoMR, et al.Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer’s disease model. J Immunol2011; 187: 6539–6549.
